Literature DB >> 15784593

Q fever pneumonia: virulence of Coxiella burnetii pathovars in a murine model of aerosol infection.

Andreas Stein1, Céline Louveau, Hubert Lepidi, Fanny Ricci, Pascal Baylac, Bernard Davoust, Didier Raoult.   

Abstract

Q fever is a worldwide zoonosis caused by Coxiella burnetii, a strictly intracellular bacterium that is a potential bioweapon. Humans usually acquires Q fever after inhalation of dust infected by subclinical animals. We used an aerosol exposure apparatus to challenge immunocompetent (BALB/c) and severe combined immunodeficient (SCID) mice with two different strains (strain Nine Mile and strain Q 212) of C. burnetii at two different inocula. Pathological lesions and dissemination of the bacteria were related to the size of the inoculum. SCID mice showed major pulmonary lesions, whereas similarly infected BALB/c mice were more able to eliminate the bacteria. Pathological differences were found between the strains, with Nine Mile showing more severe histological lesions and quantified spread of bacteria. Our animal model could provide a new tool for the study of acute Q fever pneumonia, the development of Q fever in immunodeficient hosts, and the differentiation of pathogenicity among C. burnetii isolates.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15784593      PMCID: PMC1087393          DOI: 10.1128/IAI.73.4.2469-2477.2005

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  42 in total

1.  SEROLOGIC ANALYSIS OF A PENITENTIARY GROUP USING RAW MILK FROM A Q FEVER INFECTED HERD.

Authors:  W W BENSON; D W BROCK; J MATHER
Journal:  Public Health Rep       Date:  1963-08       Impact factor: 2.792

2.  Biological properties of the M-44 strain of Coxiella burneti.

Authors:  J W Johnson; G A Eddy; C E Pedersen
Journal:  J Infect Dis       Date:  1976-03       Impact factor: 5.226

3.  Pathologic changes during acute Q fever: influence of the route of infection and inoculum size in infected guinea pigs.

Authors:  B La Scola; H Lepidi; D Raoult
Journal:  Infect Immun       Date:  1997-06       Impact factor: 3.441

Review 4.  Host factors in the severity of Q fever.

Authors:  D Raoult
Journal:  Ann N Y Acad Sci       Date:  1990       Impact factor: 5.691

5.  Stability of plasmid sequences in an acute Q-fever strain of Coxiella burnetii.

Authors:  J E Samuel; M E Frazier; L P Mallavia
Journal:  J Gen Microbiol       Date:  1988-07

6.  Comparative virulence of intra- and interstrain lipopolysaccharide variants of Coxiella burnetii in the guinea pig model.

Authors:  A Moos; T Hackstadt
Journal:  Infect Immun       Date:  1987-05       Impact factor: 3.441

7.  Route of infection determines the clinical manifestations of acute Q fever.

Authors:  T J Marrie; A Stein; D Janigan; D Raoult
Journal:  J Infect Dis       Date:  1996-02       Impact factor: 5.226

8.  Cynomolgus monkey model for experimental Q fever infection.

Authors:  J C Gonder; R A Kishimoto; M D Kastello; C E Pedersen; E W Larson
Journal:  J Infect Dis       Date:  1979-02       Impact factor: 5.226

9.  SCID mouse model for lethal Q fever.

Authors:  Masako Andoh; Takashi Naganawa; Akitoyo Hotta; Tsuyoshi Yamaguchi; Hideto Fukushi; Toshiaki Masegi; Katsuya Hirai
Journal:  Infect Immun       Date:  2003-08       Impact factor: 3.441

10.  Quiescent Q fever endocarditis exacerbated by cardiac surgery and corticosteroid therapy.

Authors:  B I Lev; A Shachar; S Segev; P Weiss; E Rubinstein
Journal:  Arch Intern Med       Date:  1988-07
View more
  45 in total

1.  A Q Fever Outbreak in the Netherlands: Consequences for Tissue Banking.

Authors:  Marja J van Wijk; Boris M Hogema; D Willemijn Maas; Arlinke G Bokhorst
Journal:  Transfus Med Hemother       Date:  2011-11-14       Impact factor: 3.747

2.  Role of CD4+ and CD8+ T cells in clearance of primary pulmonary infection with Coxiella burnetii.

Authors:  Amanda J Read; Sara Erickson; Allen G Harmsen
Journal:  Infect Immun       Date:  2010-03-29       Impact factor: 3.441

3.  Coxiella burnetii phase I and II variants replicate with similar kinetics in degradative phagolysosome-like compartments of human macrophages.

Authors:  Dale Howe; Jeffrey G Shannon; Seth Winfree; David W Dorward; Robert A Heinzen
Journal:  Infect Immun       Date:  2010-06-01       Impact factor: 3.441

Review 4.  Manipulation of rab GTPase function by intracellular bacterial pathogens.

Authors:  John H Brumell; Marci A Scidmore
Journal:  Microbiol Mol Biol Rev       Date:  2007-12       Impact factor: 11.056

5.  Coxiella burnetii inhibits apoptosis in human THP-1 cells and monkey primary alveolar macrophages.

Authors:  Daniel E Voth; Dale Howe; Robert A Heinzen
Journal:  Infect Immun       Date:  2007-07-02       Impact factor: 3.441

6.  Comparative genomics reveal extensive transposon-mediated genomic plasticity and diversity among potential effector proteins within the genus Coxiella.

Authors:  Paul A Beare; Nathan Unsworth; Masako Andoh; Daniel E Voth; Anders Omsland; Stacey D Gilk; Kelly P Williams; Bruno W Sobral; John J Kupko; Stephen F Porcella; James E Samuel; Robert A Heinzen
Journal:  Infect Immun       Date:  2008-12-01       Impact factor: 3.441

Review 7.  Animal models of Q fever (Coxiella burnetii).

Authors:  Kevin R Bewley
Journal:  Comp Med       Date:  2013       Impact factor: 0.982

8.  Mouse Model of Coxiella burnetii Aerosolization.

Authors:  Cléa Melenotte; Hubert Lepidi; Claude Nappez; Yassina Bechah; Gilles Audoly; Jérôme Terras; Didier Raoult; Fabienne Brégeon
Journal:  Infect Immun       Date:  2016-06-23       Impact factor: 3.441

9.  Quantitative Dextran Trafficking to the Coxiella burnetii Parasitophorous Vacuole.

Authors:  Seth Winfree; Stacey D Gilk
Journal:  Curr Protoc Microbiol       Date:  2017-08-11

10.  Host and Bacterial Factors Control Susceptibility of Drosophila melanogaster to Coxiella burnetii Infection.

Authors:  Reginaldo G Bastos; Zachary P Howard; Aoi Hiroyasu; Alan G Goodman
Journal:  Infect Immun       Date:  2017-06-20       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.